Skip to main content
    A

    Avalo Therapeutics Inc (AVTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.37
    -0.39 (-5.03%)

    Market Cap: $448.71M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Avalo Therapeutics Inc (AVTX) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Avalo Therapeutics (AVTX) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Avalo Therapeutics reported EPS of -$0.34, above the -$0.63 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    57%(21/37)
    Avg Surprise
    +0.81%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.52
    Range-$0.69 - -$0.40
    14 analysts
    Revenue Consensus
    N/A
    RangeN/A
    14 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.62
    Range-$0.74 - -$0.54
    4 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.55-12.7%
    60d ago-$0.63+1.1%
    30d ago-$0.62-0.4%
    7d ago-$0.62-0.4%
    Current-$0.62
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts

    Next Report

    AVTX has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 38 quarters below that had an estimate, AVTX beat 21 and missed 17. The widest gap in the table came in the quarter ended Sep 30, 2017, when EPS landed 500.00% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.34-$0.63-$0.66 - -$0.45+46.03%BeatN/A8N/ANov 5, 2026N/A
    Jun 30, 2026-$0.83-$0.66-$0.94 - -$0.46-25.76%MissN/A100 up, 1 downAug 6, 2026N/A
    Mar 31, 2026-$0.98-$1.03-$1.29 - -$0.84+4.85%BeatN/A51 up, 0 downMay 13, 2026N/A
    Dec 31, 2025-$0.37-$1.50-$2.17 - -$0.94+75.25%BeatN/A61 up, 0 downMar 23, 2026$59000
    Sep 30, 2025-$2.19-$1.64-$1.85 - -$1.25-33.54%Miss-323.5%40 up, 0 downNov 6, 2025N/A
    Jun 30, 2025-$1.92-$1.43-$2.02 - -$1.20-34.27%Miss-145.6%30 up, 0 downAug 7, 2025N/A
    Mar 31, 2025-$1.25-$1.60-$2.02 - -$1.19+21.88%BeatN/A20 up, 0 downApr 4, 2025N/A
    Dec 31, 2024-$2.74$1.67-$1.90 - $5.23-264.56%MissN/A20 up, 0 downMar 27, 2025$192000
    Sep 30, 2024$0.98-$1.19-$1.45 - -$0.93+182.35%BeatN/A20 up, 0 downNov 7, 2024$249000
    Jun 30, 2024$4.21-$6.70-$6.70 - -$6.70+162.84%BeatN/A10 up, 0 downJul 11, 2024N/A
    Mar 31, 2024-$141.00-$1.18-$1.18 - -$1.18N/AN/AN/A11 up, 0 downMay 13, 2024N/A
    Dec 31, 2023-$116.21-$4.80-$4.80 - -$4.80N/AN/AN/A10 up, 0 downMar 28, 2024$570000
    Sep 30, 2023-$26.40-$264.00N/A+90.00%Beat-132.4%10 up, 0 downNov 9, 2023$236000
    Jun 30, 2023-$141.60-$168.00-$214.29 - -$166.67+15.71%BeatN/A20 up, 0 downAug 3, 2023$643000
    Mar 31, 2023-$0.85-$0.97-$0.97 - -$0.97+12.37%BeatN/A10 up, 0 downMay 4, 2023$475000
    Dec 31, 2022-$249.60-$156.00-$269.05 - -$123.81-60.00%MissN/A30 up, 0 downMar 29, 2023$896000
    Sep 30, 2022$81.60-$315.20N/A+125.89%BeatN/A20 up, 0 downNov 7, 2022$14.95M
    Jun 30, 2022-$331.20-$424.80N/A+22.03%BeatN/A30 up, 0 downAug 4, 2022$1.03M
    Mar 31, 2022-$2.40-$1.60-$1.80 - -$1.44-50.00%MissN/A20 up, 0 downMay 5, 2022$1.17M
    Dec 31, 2021-$460.80-$439.20-$514.49 - -$371.58-4.92%MissN/A50 up, 0 downMar 2, 2022$220000
    Sep 30, 2021-$489.60-$518.40-$600.24 - -$428.74+5.56%BeatN/A5N/ANov 9, 2021$1.35M
    Jun 30, 2021-$518.40-$508.80N/A-1.89%MissN/AN/AN/AAug 2, 2021$3.35M
    Mar 31, 2021-$3.84-$2.32N/A-65.52%MissN/AN/AN/AMay 13, 2021$473000
    Dec 31, 2020-$489.60-$432.00N/A-13.33%Miss-136100.0%N/AN/AMar 8, 2021$1.50M
    Sep 30, 2020-$460.80-$273.60N/A-68.42%MissN/AN/AN/ANov 9, 2020$1.11M
    Jun 30, 2020-$472.89-$302.40N/A-56.38%MissN/AN/AN/AAug 6, 2020$1.34M
    Mar 31, 2020-$247.39-$355.20N/A+30.35%BeatN/AN/AN/AMay 7, 2020$2.75M
    Dec 31, 2019$0.36$0.84N/A-57.14%MissN/AN/AN/AMar 11, 2020$557177
    Sep 30, 2019-$213.23-$388.80N/A+45.16%BeatN/AN/AN/ANov 14, 2019$2.20M
    Jun 30, 2019-$292.61-$470.40N/A+37.80%BeatN/AN/AN/AAug 8, 2019$1.39M
    Mar 31, 2019-$362.88-$470.40N/A+22.86%BeatN/AN/AN/AMay 9, 2019$2.60M
    Dec 31, 2018-$2.16-$0.60N/A-260.00%MissN/AN/AN/AMar 18, 2019$7.29M
    Sep 30, 2018-$2,044.78-$345.60N/A-491.66%Miss-236.5%N/AN/ANov 13, 2018$4.07M
    Jun 30, 2018-$547.20-$288.00N/A-90.00%MissN/AN/AN/AAug 9, 2018$4.79M
    Mar 31, 2018-$316.80-$662.39N/A+52.17%BeatN/AN/AN/AApr 2, 2018$4.48M
    Sep 30, 2017$1,497.59-$374.40N/A+500.00%BeatN/AN/AN/ANov 6, 2017$25.04M
    Jun 30, 2017-$403.20-$633.60N/A+36.36%BeatN/AN/AN/AAug 14, 2017$157800
    Mar 31, 2017-$2.28-$4.44N/A+48.65%BeatN/AN/AN/AMay 9, 2017$384206
    Dec 31, 2016-$549.85-$1,785.59N/A+69.21%BeatN/AN/AN/AMar 14, 2017$181002
    Sep 30, 2016-$1,995.77-$1,411.19N/A-41.42%MissN/AN/AN/ANov 8, 2016$321497
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$5.73, after -$138.55 the year before. It was -$6.44 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$5.73N/A
    Dec 31, 2024-$138.55N/A
    Dec 31, 2023-$285.06N/A
    Dec 31, 2022-$501.60N/A
    Dec 31, 2021-$1,472.64N/A
    Dec 31, 2020-$1,670.68N/A
    Dec 31, 2019-$868.36N/A
    Dec 31, 2018-$1,818.83N/A
    Dec 31, 2016-$5,445.18N/A
    Dec 31, 2015-$6.44N/A

    Frequently Asked Questions About AVTX

    When is Avalo Therapeutics's next earnings date?

    Avalo Therapeutics's next earnings report is expected for Mar 22, 2027.

    Did AVTX beat earnings estimates last quarter?

    Yes. Avalo Therapeutics reported EPS of -$0.34 for the quarter ended Sep 30, 2026, above the -$0.63 estimate, a 46.03% surprise.

    What EPS do analysts expect from AVTX next quarter?

    The consensus EPS estimate for Avalo Therapeutics for the quarter ending Dec 31, 2026 is -$0.52 from 14 analysts, with estimates from -$0.69 to -$0.40.

    How often does AVTX beat earnings estimates?

    Avalo Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -26.26%.